Drug Search Results
More Filters [+]

BTL EMSELLA

Alternative Names: BTL EMSELLA
Latest Update: 2024-11-07
Latest Update Note: Clinical Trial Update

Product Description

BTL EMSELLA uses HIFEM technology for PFM strengthening and reduction of UI. The device is consisted of a power generator and a circular coil mounted in the seat of the chair.  (Sourced from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016513/)

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Colombia

Approved Indications: None

Known Adverse Events: None

Company: William Beaumont Hospitals
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for BTL EMSELLA

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT04133675

N/A

Recruiting

Urinary Incontinence, Stress|Enuresis

2027-10-01

Emsella_EJD

N/A

Recruiting

Aging, Premature|Liver Failure|Pelvic Pain|Premature Ejaculation|Erectile Dysfunction

2026-07-01

EmsellaOAB

N/A

Recruiting

Overactive Bladder

2026-06-01

NCT04031014

N/A

Recruiting

Overactive Bladder|Urinary Incontinence, Urge|Urinary Incontinence, Stress|Enuresis

2025-07-01

Recent News Events

Date

Type

Title